Jobs
Caribou Biosciences

Caribou Biosciences
CRISPR genome editing company
Gene Editing
Cell Therapy
Immunotherapy
Biotechnology
Drug Development
Open Positions
7 positions
VP, General Manager Lending
Chicago, IL | Denver, CO | Phoenix, AZ | Remote, US
On-site
VP
Full-time
$200,000 - $240,000
Healthcare
Equity
1w ago
Titling Agent
Denver, Colorado, United States
On-site
Full-time
$49,920 - $54,080
Healthcare
Equity
1w ago
Senior Manager, Go-To-Market Operations
Chicago, IL | Denver, CO | Phoenix, AZ | Remote, US
On-site
Lead
Full-time
$120,000 - $150,000
Healthcare
Equity
1w ago
Principal Product Manager - Horizon Initiatives
Chicago, IL | Denver, CO | Phoenix, AZ | Remote, US
On-site
Staff
Full-time
$173,000 - $217,000
Equity
1w ago
Manager, Sales Support
Denver, Colorado, United States
On-site
Lead
Full-time
$80,000 - $100,000
Equity
1w ago
Don't See What You're Looking For?
Remote - U.S.
On-site
Full-time
1w ago
Director, Direct Mail Growth
Chicago, IL | Denver, CO | Phoenix, AZ | Remote, US
On-site
Director
Full-time
$140,000 - $175,000
Equity
1w ago
Products & Services
CB
CB-010
Cell Therapy
CB
CB-011
Cell Therapy
CB
CB-012
Cell Therapy
CH
chRDNA Platform
Platform Technology
CR
CRISPR Manufacturing Services
Manufacturing Services
GE
Genome Editing Tools
Research Tools
Similar Companies

Mass General Brigham
Public
Healthcare system
Boston, MA
10,001+
1688 open jobs

Equinox
Series B
Luxury fitness club chain
Newport Beach, California, United States
1-50

Clover Health
Public
Technology-driven health insurance company
Franklin, Tennessee
501-1,000
75 open jobs

NYU Langone
Public
Academic medical center
New York, NY
10,001+

CSX
Focused on rail transportation and real estate in North America, among other industries.
Auckland, Auckland, New Zealand
1-50

Medtronic
Public
Medical device company.
Minneapolis, Minnesota, United States
10,001+
776 open jobs
News & Buzz
All
X
News
HN
YouTube
Caribou Biosciences (NASDAQ:CRBU) Shares Up 0.6% - Should You Buy? - MarketBeat
Source: MarketBeat
google-news
·
1mo ago
Caribou Biosciences (CRBU) Upgraded to Buy: Here's Why - Yahoo Finance
Source: Yahoo Finance
google-news
·
1mo ago
CRISPR PD-1 knockout allogeneic CAR-T matches autologous - CRISPR Medicine News
Source: CRISPR Medicine News
google-news
·
3mo ago
Caribou’s off-the-shelf CAR-T therapy shows promise in lymphoma study - statnews.com
Source: statnews.com
google-news
·
4mo ago
Caribou Biosciences: A Much Anticipated Data Readout Does Not Quite Get My Buy - Seeking Alpha
Source: Seeking Alpha
google-news
·
4mo ago
More (5 remaining)
Total Views
0
Apply Clicks
0
Mock Applicants
0
Scraps
0
Reviews
3.7
1 reviews
Work Life Balance
3.5
Compensation
3.5
Culture
3.5
Career
4.0
Management
3.5
75%
Recommend to a Friend
Pros
Clinical-stage biopharmaceutical company with promising pipeline
Multiple lead product candidates in development
Focus on hematologic malignancies and solid tumors
Cons
Limited review data available
No specific concerns mentioned
Potential early-stage company risks
Salary Ranges
22 data points
Mid/L4
Senior/L5
Mid/L4
2 reports
$195,000
total / year
Base
$150,000
Stock
-
$195,000
$195,000
Interview Experience
52 interviews
Difficulty
3.2
/ 5
Duration
2-5w
Offer Rate
42%
Experience
Positive 61%
Neutral 24%
Negative 15%
Interview Process
1
Phone Screen
2
Technical Interview
3
Hiring Manager
4
Team Fit
Contact & Location